Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.970
+0.130 (4.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
Repare Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 126 | 308 | 617 | 880 | 1,261 | - | |
| Market Cap Growth | -71.29% | -50.18% | -29.87% | -30.20% | - | - | |
| Enterprise Value | -56 | 61 | 253 | 619 | 917 | - | |
| Last Close Price | 2.84 | 7.30 | 14.71 | 21.09 | 34.30 | - | |
| PS Ratio | 1.81 | 6.01 | 4.68 | 115.81 | 9341.04 | - | |
| PB Ratio | 0.69 | 1.45 | 2.21 | 3.05 | 4.40 | - | |
| P/TBV Ratio | 0.83 | 1.45 | 2.21 | 3.05 | 4.40 | - | |
| P/OCF Ratio | - | - | 1916.94 | - | - | - | |
| EV/Sales Ratio | - | 1.20 | 1.92 | 81.46 | 6794.23 | - | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | |
| Asset Turnover | 0.27 | 0.17 | 0.36 | 0.02 | 0.00 | - | |
| Quick Ratio | 6.23 | 6.11 | 4.43 | 9.83 | 30.86 | 23.05 | |
| Current Ratio | 6.45 | 6.24 | 4.50 | 10.01 | 31.46 | 23.22 | |
| Return on Equity (ROE) | -41.17% | -38.16% | -10.23% | -37.17% | -28.36% | -54.78% | |
| Return on Assets (ROA) | -23.39% | -23.51% | -3.38% | -18.71% | -14.76% | -28.27% | |
| Return on Capital (ROIC) | -27.79% | -29.03% | -4.26% | -23.16% | -17.78% | -32.04% | |
| Earnings Yield | -66.57% | -30.50% | -4.71% | -12.15% | -4.24% | - | |
| FCF Yield | -61.52% | -41.98% | -0.05% | -9.94% | -0.66% | - | |
| Buyback Yield / Dilution | -0.63% | -0.41% | -10.85% | -88.66% | -1211.56% | - | |
| Total Shareholder Return | -0.63% | -0.41% | -10.85% | -88.66% | -1211.56% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.